Ingredient Evidence Review

Horny Goat Weed in Nitric Boost Ultra

Review of horny goat weed in Nitric Boost Ultra, icariin, PDE5-related mechanisms, human evidence limitations, standardization and safety.

CHECK CURRENT OFFER READ THE ANALYSIS

Desk ResearchEvidence LabelsSafety ContextUpdated Aug 2026

Horny Goat Weed in Nitric Boost Ultra visual

Botanical evidence

Horny goat weed has interesting preclinical mechanisms but limited robust human outcome data.

Horny goat weed commonly refers to Epimedium species. The compound icariin and related flavonoids have attracted attention because laboratory studies have explored phosphodiesterase-5-related activity and other vascular mechanisms.

That preclinical work is scientifically interesting, particularly because PDE5 is also a pharmacological target in established erectile-dysfunction medicines. But demonstrating enzyme activity in a laboratory setting is not the same as showing that a commercial horny-goat-weed dose produces a clinically meaningful response in men.

For Nitric Boost Ultra, strong human evidence specific to the horny-goat-weed component has not been established from the material reviewed.

Illustrative Nitric Boost Ultra visual for horny goat weed evidence discussion

Evidence ladder

Where the horny-goat-weed evidence currently sits.

Mechanistic interest

Yes. Icariin and related compounds have been examined for PDE5-related and vascular activity.

Human clinical evidence

Limited. The evidence is not comparable in depth or certainty with approved ED therapies.

Product-specific evidence

Not established. Dose, species, extract and standardization remain important unknowns.

Botanical standardization

The common name does not define the intervention.

Herbal products can differ by species, plant part, extraction method and concentration of marker compounds. “Horny goat weed” on a label does not tell a researcher how much icariin or other relevant compound is present.

A trial using a defined standardized extract would therefore not automatically apply to a different commercial botanical mixture. This is one reason MPS avoids implying that preclinical icariin research proves Nitric Boost Ultra efficacy.

Safety context

Traditional use is not the same as interaction-free use.

Botanicals can have pharmacological activity and can interact with medicines or other supplements. Individual risks depend on dose, health status and co-administered products.

Read the complete safety and interaction review →

MPS assessment

Preclinical interest: yes. Strong clinical proof for this product: no.

Horny goat weed is a plausible traditional/experimental component, but it should not be used as a shortcut to claim that Nitric Boost Ultra has an established PDE5-like clinical effect.

Selected references

Research trail

Rhim HC, Kim MS, Park YJ, et al. Arginine supplements and erectile dysfunction: systematic review and meta-analysis. PubMed PMID 30770070.
Cormio L, De Siati M, Lorusso F, et al. Oral L-citrulline supplementation in men with mild erectile dysfunction. PubMed PMID 21195829.
Xu Z, Liu C, Liu S, Zhou Z. L-arginine and PDE5 inhibitors in erectile dysfunction: systematic review/meta-analysis. PubMed PMID 33587304.
D'Aniello G, et al. D-aspartic acid and testosterone: systematic review. PubMed PMID 28280794.
Current merchant/product materials supplied for this project, reviewed August 21, 2026. Product formulation, prices, bonuses and guarantee statements are treated as merchant representations rather than independent efficacy evidence.

References are included for research context. Evidence on a constituent ingredient does not automatically validate the finished product.

Current merchant offer

Compare the current Nitric Boost Ultra package options.

The supplied merchant materials reviewed August 21, 2026 show one-, three- and six-jar packages. Commercial terms can change; verify the live checkout before purchasing.